Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
2011

Improving Antiplatelet Therapy with a Tailored Approach

Sample size: 504 publication 10 minutes Evidence: high

Author Information

Author(s): Horst Neubauer, Andreas Kaiser, Heinz Endres, Jan Krüger, Andreas Engelhardt, Sebastian Lask, Fenena Pepinghege, Andreas Kusber, Andreas Mügge

Primary Institution: Cardiovascular Center, Ruhr University Bochum

Hypothesis

A standardized therapeutic algorithm can reduce the prevalence of clopidogrel and aspirin low response.

Conclusion

Following a structured therapy plan based on a 'test and treat' strategy, the prevalence of clopidogrel or aspirin low response can be significantly reduced.

Supporting Evidence

  • 30.8% of patients were identified as clopidogrel low responders.
  • 19.4% of patients were identified as aspirin low responders.
  • After dose adjustments, 94.6% of aspirin low responders were effectively treated.
  • The prevalence of clopidogrel low response was reduced by 86.6% with the therapy algorithm.

Takeaway

This study shows that by testing how well patients respond to blood thinners and adjusting their doses, we can help more people avoid heart problems after stenting.

Methodology

Platelet function testing was performed using whole blood aggregometry on patients following coronary stenting, with adjustments made to antiplatelet therapy based on test results.

Potential Biases

Potential biases may arise from the non-randomized design and reliance on specific platelet function tests.

Limitations

The study is observational and non-randomized, and the cut-off values and methods used have limitations.

Participant Demographics

Mean age was 64.3 years, 30.5% were female, and 67.8% had acute coronary syndrome.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1741-7015-9-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication